BrightGene Bio-Medical Technology Co., Ltd. Share Price
Equities
688166
CNE100003PR1
Pharmaceuticals
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
30.99 CNY | +0.91% | +20.21% | -11.46% |
Sales 2021 | 1.05B 145M 11.62B | Sales 2022 | 1.02B 141M 11.24B | Capitalization | 9.54B 1.32B 105B |
---|---|---|---|---|---|
Net income 2021 | 244M 33.7M 2.7B | Net income 2022 | 240M 33.15M 2.65B | EV / Sales 2021 | 14.8 x |
Net Debt 2021 | 565M 78.02M 6.24B | Net Debt 2022 | 791M 109M 8.74B | EV / Sales 2022 | 10.2 x |
P/E ratio 2021 |
61.2
x | P/E ratio 2022 |
38.9
x | Employees | 1,128 |
Yield 2021 |
0.33% | Yield 2022 |
0.51% | Free-Float | 48.25% |
1 day | +0.91% | ||
1 week | +20.21% | ||
Current month | +5.84% | ||
1 month | +5.84% | ||
3 months | +15.76% | ||
6 months | -24.98% | ||
Current year | -11.46% |
Managers | Title | Age | Since |
---|---|---|---|
Jian Dong Yuan
CEO | Chief Executive Officer | 54 | 25/10/01 |
Yuan Lai Zou
DFI | Director of Finance/CFO | 53 | 31/12/10 |
Fan Hang
BRD | Director/Board Member | 38 | 31/12/05 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jian Dong Yuan
CEO | Chief Executive Officer | 54 | 25/10/01 |
Simon Lü
BRD | Director/Board Member | 56 | 12/05/17 |
Yang Qing Huang
BRD | Director/Board Member | 43 | 31/12/08 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 34 M€ | +1.85% | - |
Date | Price | Change | Volume |
---|---|---|---|
29/04/24 | 30.99 | +0.91% | 9 441 323 |
29/04/24 | 30.71 | +3.82% | 12,913,130 |
26/04/24 | 29.58 | +3.72% | 12,162,740 |
25/04/24 | 28.52 | +4.51% | 11,525,650 |
24/04/24 | 27.29 | +3.18% | 5,395,480 |
End-of-day quote Shanghai S.E., April 29, 2024
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-11.46% | 1.79B | |
+33.53% | 664B | |
+29.29% | 567B | |
-7.14% | 354B | |
+19.14% | 330B | |
+4.74% | 286B | |
+13.79% | 234B | |
+4.93% | 199B | |
-9.78% | 196B | |
-4.68% | 148B |
- Stock Market
- Equities
- 688166 Stock